Final Outcomes from a Phase 2 Trial of Posoleucel in Allogeneic Hematopoietic Cell Transplant Recipients.
Dadwal SS, Bansal R, Schuster M, Yared JA, Myers GD, Matzko ME, Adnan S, McNeel D, Ma J, Gilmore SA, Vasileiou S, Leen AM, Hill JA, Young JA.
Dadwal SS, et al. Among authors: schuster m.
Blood Adv. 2024 Apr 9:bloodadvances.2023011562. doi: 10.1182/bloodadvances.2023011562. Online ahead of print.
Blood Adv. 2024.
PMID: 38593233